Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jan;65(1):162-9.
doi: 10.1128/JVI.65.1.162-169.1991.

Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range

Affiliations

Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range

N R Landau et al. J Virol. 1991 Jan.

Abstract

Several epidemiologic and clinical studies suggest that patients coinfected with human immunodeficiency virus (HIV), the primary etiologic agent in AIDS, and other viruses, such as cytomegalovirus or human T-cell leukemia virus (HTLV), have a more severe clinical course than those infected with HIV alone. Cells infected with two viruses can, in some cases, give rise to phenotypically mixed virions with altered or broadened cell tropism and could therefore account for some of these findings. Such pseudotypes could alter the course of disease by infecting more tissues than are normally infected by HIV. We show here that HIV type 1 (HIV-1) efficiently incorporates the HTLV type I (HTLV-I) envelope glycoprotein and that both HIV-1 and HTLV-II accept other widely divergent envelope glycoproteins to form infectious pseudotype viruses whose cellular tropisms and relative abilities to be transmitted by cell-free virions or by cell contact are determined by the heterologous envelope. We also show that the mechanism by which virions incorporate heterologous envelope glycoproteins is independent of the presence of the homologous glycoprotein or heterologous gag proteins. These results may have important implications for the mechanism of HIV pathogenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759-63 - PubMed
    1. J Virol. 1976 Jul;19(1):19-25 - PubMed
    1. J Virol. 1989 Jun;63(6):2527-33 - PubMed
    1. J Virol. 1989 Feb;63(2):970-3 - PubMed
    1. Science. 1988 Dec 16;242(4885):1557-9 - PubMed

Publication types

Substances

LinkOut - more resources